We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.26%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
+$546M
(+11%)
Cap. Flow
+$263M
Cap. Flow
% of AUM
4.63%
Top 10 Holdings %
Top 10 Hldgs %
11.85%
Holding
1,134
New
196
Increased
491
Reduced
251
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$35.7M |
| 2 |
Merck
MRK
|
+$30.3M |
| 3 |
Microsoft
MSFT
|
+$22.4M |
| 4 |
Yum China
YUMC
|
+$17.6M |
| 5 |
Occidental Petroleum
OXY
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$36.5M |
| 2 |
Intel
INTC
|
+$32.4M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$17.1M |
| 4 |
NVR
NVR
|
+$16.3M |
| 5 |
Deere & Co
DE
|
+$16.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Financials | 17.92% |
| 3 | Industrials | 13.48% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Healthcare | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.7T
| $119M | 2.1% |
2,821,796
+270,240
| +11% | +$11.3M |
|
2
Alphabet (Google) Class C
GOOG
$3.9T
| $115M | 2.02% |
2,196,200
+95,180
| +5% | +$4.84M |
|
3
Amazon
AMZN
$2.51T
| $88.9M | 1.56% |
1,520,520
+56,880
| +4% | +$3.13M |
|
|
4
Microsoft
MSFT
$2.83T
| $83.8M | 1.47% |
979,438
+273,240
| +39% | +$22.4M |
|
5
Boeing
BA
$163B
| $52.3M | 0.92% |
177,458
-8,034
| -4% | -$2.17M |
|
6
PepsiCo
PEP
$184B
| $45.8M | 0.8% |
381,563
-6,130
| -2% | -$700K |
|
7
ExxonMobil
XOM
$653B
| $44.4M | 0.78% |
530,475
-193,760
| -27% | -$16M |
|
8
Philip Morris
PM
$296B
| $42.4M | 0.75% |
401,664
+126,952
| +46% | +$13.5M |
|
9
Voya Financial
VOYA
$8.76B
| $41.3M | 0.73% |
834,460
-66,440
| -7% | -$2.86M |
|
|
10
Merck
MRK
$322B
| $40.9M | 0.72% |
761,845
+545,788
| +253% | +$30.3M |
|
|
WCG
11
DELISTED
Wellcare Health Plans, Inc.
WCG
| $39.5M | 0.69% |
196,451
+8,840
| +5% | +$1.71M |
|
12
Elevance Health
ELV
$82B
| $37.1M | 0.65% |
164,776
-11,580
| -7% | -$2.47M |
|
13
Visteon
VC
$2.65B
| $36.6M | 0.64% |
292,602
+27,010
| +10% | +$3.42M |
|
14
Allstate
ALL
$65.4B
| $36.5M | 0.64% |
348,530
+5,620
| +2% | +$554K |
|
|
15
Bristol-Myers Squibb
BMY
$126B
| $36.1M | 0.64% |
589,809
+571,189
| +3,068% | +$35.7M |
|
16
Landstar System
LSTR
$7.01B
| $34.2M | 0.6% |
328,448
+18,900
| +6% | +$1.9M |
|
17
Domino's
DPZ
$10.5B
| $33.8M | 0.59% |
178,630
+18,420
| +11% | +$3.41M |
|
18
Marvell Technology
MRVL
$185B
| $33.7M | 0.59% |
1,570,387
-258,866
| -14% | -$5.28M |
|
19
Caterpillar
CAT
$413B
| $32.9M | 0.58% |
208,673
+94,754
| +83% | +$13.1M |
|
20
Synopsys
SNPS
$71.5B
| $32.4M | 0.57% |
380,104
-9,510
| -2% | -$823K |
|
21
NetApp
NTAP
$32.2B
| $32M | 0.56% |
578,975
-299,700
| -34% | -$15M |
|
22
American International
AIG
$41.6B
| $31.8M | 0.56% |
534,467
+20,890
| +4% | +$1.28M |
|
23
ManpowerGroup
MAN
$2.32B
| $31.7M | 0.56% |
250,997
-342
| -0.1% | -$42.7K |
|
24
Humana
HUM
$46.9B
| $31.4M | 0.55% |
126,554
+4,829
| +4% | +$1.19M |
|
25
General Motors
GM
$72B
| $30.9M | 0.54% |
753,039
-38,400
| -5% | -$1.67M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2017 Portfolio in Review
As of Q4 2017, Jacobs Levy Equity Management held 1,134 positions worth $5.69B, up 11% from $5.14B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management deployed $263M of net new capital in Q4 2017, opening 196 new positions and adding to 491 existing holdings. Its largest new stake was Yum China: 427,927 shares worth $17.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $36.5M trimmed.
- Jacobs Levy Equity Management's largest Q4 2017 buy was Yum China: 427,927 shares worth $17.1M.
- Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q4 2017, an estimated $35.7M increase.
- Jacobs Levy Equity Management's biggest Q4 2017 reduction was Johnson & Johnson, cutting an estimated $36.5M.
- Jacobs Levy Equity Management fully exited Twenty-First Century Fox, Inc. Class A in Q4 2017, selling an estimated $17.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.69B portfolio in Q4 2017.
- Jacobs Levy Equity Management opened 196 new positions and closed 159 in Q4 2017.
- Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $5.69B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2017, filed 13 Feb 2018.